About: Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.50 (-9.84%)
JSPR NASDAQ Jasper Therapeutics Inc
Jasper Therapeutics Inc share price
JSPR price activity
Last Price
$0.500
Change (24hr)
-0.05 USD (-9.84%)
Volume
246.79K
Volume (4w avg)
-
Open
$0.54
Day Range
$0.50 - $0.54
Previous Close
$0.56
Last Trade
13 Oct, 4:23 pm GMT+0
Delayed
13 Oct, 4:23 pm GMT+0
JSPR price performance
Delayed
13 Oct, 4:23 pm GMT+0
JSPR Market Signals